Estrogen regulation of endothelial and smooth muscle cell migration and proliferation: Role of p38 and p42/44 mitogen-activated protein kinase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 10, 2002, Pages 1585-1590

  Geraldes, Pedro ^a   Sirois, Martin G ^b   Bernatchez, Pascal N ^b   Tanguay, Jean François ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

17 estradiol; Endothelium; Mitogen activated protein kinase; Smooth muscle

Indexed keywords

ANTIESTROGEN; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P42; PROTEIN P44; RALOXIFENE; SYNAPTOPHYSIN; TAMOXIFEN;

ANGIOPLASTY; ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART PROTECTION; HORMONE ACTION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SWINE;

ANIMALS; AORTA; CELL DIVISION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGENS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, ESTROGEN; SWINE; TUNICA INTIMA;

EID: 0036791543     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000035393.11854.6A     Document Type: Article

References (28)

1. Chandrasekar B, Tanguay JF. Platelets and restenosis. J Am Coll Cardiol. 2000;35:555-562.
2. Cignarella A, Paoletti R, Puglisi L. Direct effects of estrogen on the vessel wall. Med Res Rev. 2001;21:171-184.
3. Dubey RK, Jackson EK, Gillespie DG, Zacharia LC, Imthurn B, Keller PJ. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol. 2000;20:964-972.
4. Song J, Wan Y, Rolfe BE, Campbell JH, Campbell GR. Effect of estrogen on vascular smooth muscle cells is dependent upon cellular phenotype. Atherosclerosis. 1998;140:97-104.
5. Lavigne MC, Ramwell PW, Clarke R. Inhibition of estrogen receptor function promotes porcine coronary artery smooth muscle cell proliferation. Steroids. 1999;64:472-480.
6. Kolodgie FD, Jacob A, Wilson PS, Carlson GC, Farb A, Verma A, Virmani R. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol. 1996;148:969-976.
7. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol. 1997;273: L119-L126.
8. Herrington D. Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection. Can J Cardiol. 2000;16(suppl E):5E-9E.
9. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000;106:1229-1237.
10. Silbiger S, Lei J, Ziyadeh FN, Neugarten J. Estradiol reverses TGF-beta1-stimulated type IV collagen gene transcription in murine mesangial cells. Am J Physiol. 1998;274:F1113-F1118.
11. Chandrasekar B, Tanguay JF. Local delivery of 17-beta-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model. J Am Coll Cardiol. 2000;36:1972-1978.
12. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
13. Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38 MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol. 1999;145:727-740.
14. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem. 2001;276:36869-36872.
15. Chevalier D, Thorin E, Allen BG. Simultaneous measurement of ERK, p38, and JNK MAP kinase cascades in vascular smooth muscle cells. J Pharmacol Toxicol Methods. 2000:44:429-439.
16. Matsumoto T, Yokote K, Tamura K, Takemoto M, Ueno H. Saito Y, Mori S. Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J Biol Chem. 1999;274:13954-13960.
17. Simoncini T, Genazzani AR. Direct vascular effects of estrogens and selective estrogen receptor modulators. Curr Opin Obstet Gynecol. 2000:12:181-187.
18. Nadal A, Diaz M, Valverde MA. The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol Sci. 2001;16:251-255.
19. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circ Res. 200 1;89:534-539.
20. Finking G, Krauss N, Romer S, Eckert S, Lenz C, Kamenz J. Menke A, Brehme U. Hombach V, Hanke H. 17β-Estradiol, gender independently reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta. Atherosclerosis. 2001;154:39-49.
21. van Baal WM, Kenemans P, Emeis JJ, Schalkwijk CG, Mijatovic V. van der Mooren MJ, Vischer UM, Stehouwer CD. Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women. Fertil Steril. 1999;71:663-670.
22. Chandrasekar B, Nattel S, Tanguay JF. Coronary artery endothelial protection after local delivery of 17beta-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function. J Am Coll Cardiol. 2001:38:1570-1576.
23. Dubey RK, Jackson EK, Gillespie DG, Zacharia LC, Imthurn B, Keller PJ. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol. 2000;20:964-972.
24. Clarke SC, Schofield PM, Grace AA, Metcalfe JC. Kirschenlohr HL. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis. Circulation. 2001;103:1497-1502.
25. Sader MA, McCredie RJ, Griffiths KA, Wishart SM, Handelsman DJ, Celermajer DS. Oestradiol improves arterial endothelial function in healthy men receiving testosterone. Clin Endocrinol (Oxf). 2001:54:175-181.
26. Shaul PW. Novel role of estrogen receptors in vascular endothelium. Semin Perinatol. 2000;24:70-74.
27. Razandi M, Pedram A, Levin ER. Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem. 2000;275:38540-38546.
28. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA. 2000;97:5930-5935.